Crossmark

ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis

Crossref DOI link: https://doi.org/10.1186/s13058-018-0992-0

Published Online: 2018-07-11

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dumortier, Mandy

Ladam, Franck

Damour, Isabelle

Vacher, Sophie

Bièche, Ivan

Marchand, Nathalie

de Launoit, Yvan

Tulasne, David

Chotteau-Lelièvre, Anne
License Information

Text and Data Mining valid from 2018-07-11
More Information

Article History

Received: 20 September 2017

Accepted: 23 May 2018

First Online: 11 July 2018

Ethics approval

: All animal studies were approved by the CEEA Nord - Pas de Calais n°75 Ethics Committee for Animal Experiments. Female mice (age-matched, between 6 and 8 weeks old) homozygous for SCID were used for grafting studies. Regarding human breast tumors, all patients cared for in our institution before 2007 were informed that their tumor samples might be used for scientific purposes and had the opportunity to decline. Since 2007, patients treated in our institution have given their approval by signed informed consent. This study was approved by the local ethics committee (Breast Group of Curie Institute - René Huguenin Hospital).

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.